Table 2:
Excluded studies with reasons.
| Study (Year) | Reason |
|---|---|
| Alvarez-Perez et al., 2012[51] | No non-active cancer group |
| Amiri-Nikpour and Husseinzadeh, 2016[23] | Full text not available |
| Bang et al., 2023[24] | No separate group to answer research question |
| Bonnerot et al., 2016[25] | No non-active cancer group |
| Cen et al., 2023[26] | No non-active cancer group |
| Di Castelnuovo et al., 2014[27] | Patients with coronary artery disease did not answer |
| Ellis et al., 2018[28] | Study does not separately provide D-dimer data in cancer patients |
| Markus, 2020[29] | Editorial |
| Ito et al., 2018[30] | No non-active cancer group |
| Kim et al., 2021[17] | No well-defined cancer and non-cancer groups |
| Kono et al., 2012[10] | Detailed FDP values not available separate for cancer and non-cancer groups |
| Liu et al., 2021[31] | Study does not separately provide D-dimer data in cancer patients |
| Nahab et al., 2020[32] | Study does not separately provide D-dimer data in cancer patients |
| Nakajima et al., 2022[15] | No non-active cancer group |
| Nam et al., 2017[33] | No non-active cancer group |
| Nam et al., 2023[34] | No non-active cancer group |
| Nezu et al., 2018[35] | No non-active cancer group |
| Nickel et al., 2021[36] | Mix of population, no separate cancer group |
| Ohara et al., 2020[13] | Review article |
| Pan et al., 2021[38] | Study does not separately provide D-dimer data in cancer patients |
| Pan et al., 2022[37] | No non-active cancer group |
| Pieper et al., 2000[39] | Mix of population |
| Rodrigues et al., 2014[40] | Conference abstract |
| Rosenberg et al., 2020[41] | Study does not separately provide D-dimer data in cancer patients |
| Ryu et al., 2017[42] | No non-active cancer group |
| Schultz et al., 2022[43] | Conference abstract |
| Shen et al., 2020[44] | Study does not separately provide D-dimer data in cancer patients |
| Tardy et al., 1998[45] | Study does not separately provide D-dimer data in cancer patients |
| Tsushima et al., 2020[46] | No non-active cancer group |
| Wang et al., 2022[47] | No non-active cancer group |
| Wei et al., 2020[48] | No non-active cancer group |
| Yamaguchi et al., 2019[49] | No non-active cancer group |
| Zhang et al., 2019[50] | Systematic review and meta-analyses |
FDP: Fibrinogen degradation products